Among patients evaluated for a mpox-compatible rash, the preva – lence of mpox is 1.5%, according to research published in MMWR. Carl T. Berdahl, MD, and col – leagues screened for mpox reemergence and examined potentially unsuspected cases among non-gay and bisexual men who have sex with men (GBMSM) by conducting surveillance at 13 US EDs. A total of 196 persons were enrolled; 55.1% were males and 6.6% were GBMSM. Nearly half of enrollees (46.4%) were non-Hispanic White; 38.8% re – ported Hispanic or Latino ethnicity. Overall, 10.7% of enrollees reported unstable housing, while 12.2% lacked health insurance. Among ED patients evaluated for an mpox-compatible rash, the prevalence of mpox was 1.5%. All pa – tients with a confirmed mpox diagnosis identi – fied as GBMSM, reported being HIV-negative, not being vaccinated against mpox, and having sex with at least one partner met through a dat – ing app. There were no cases among women or unhoused persons. The findings “underscore the importance of educating persons at risk for mpox regarding behavioral risks and en – couraging these persons to be vaccinated,” Dr. Berdahl and colleagues wrote.